Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | RNK05047 |
Synonyms | |
Therapy Description |
Limited information is currently available on RNK05047, a putative BRD4-selective degrader (Aug 2022). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
RNK05047 | RNK-05047|RNK 05047 | BRD4 Inhibitor 10 | Limited information is currently available on RNK05047, a putative BRD4-selective degrader (Aug 2022). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05487170 | Phase Ib/II | RNK05047 | A Study of RNK05047 in Subjects With Advanced Solid Tumors/Diffuse Large B-cell Lymphoma (CHAMP-1) | Recruiting | USA | 0 |